This review focuses on health beneficial aspects of omega-3 fatty acids and microencapsulation technologies to prevent oxidation and off flavour formation in foods. The paper is broadly divided thematically in three sections. First section of this review discusses the biochemistry of omega-3 fatty acids, their classification and formation of off flavours due to oxidation of omega-3 fatty acids....

The aim of this research was to enhance bioethanol production via immobilization and microencapsulation of Saccharomyces cerevisiae CICC 1001 into delignified cellulosic material (DCM), prepared from sawdust and Na alginate. It has been demonstrated that microencapsulation process using Alginate: DCM ratio of (1:1.5) and alginate solution of 2.5% by wt, attained the highest microencapsulation e...

Microencapsulation may be defined as the process of surrounding or enveloping one substance within another substance on a very small scale, yielding capsules ranging from less than one micron to several hundred microns in size. Drug discovery and delivery to retard the degeneration of joint tissues are challenging. Current treatment of different arthritis involves administration of ideal nonste...

Encapsulation, invented in 1953 by B.K. Green & L. Schleicher employed in the laboratories of the National Cash Register Company, Dayton, USA, is defned as a technology of packaging solids, liquids, or gaseous materials in miniature, sealed capsules that can release their contents at controlled rates under specifc conditions. Encapsulation involves the incorporation of ...

Nifedipine (NIF), a 1,4-dihydropyridine calcium channel antagonist, undergoes photo-degradation to dehydro-nifedipine (DNIF) upon exposure to ultraviolet (UV) light and to the nitroso analogue of dehydro-nifedipine (NDNIF) when exposed to sunlight or some kinds of artificial lights. NIF photo-degradation products do not contribute to clinical activity, thus prevention of photo-degradation of NI...

Nifedipine (NIF), a 1,4-dihydropyridine calcium channel antagonist, undergoes photo-degradation to dehydro-nifedipine (DNIF) upon exposure to ultraviolet (UV) light and to the nitroso analogue of dehydro-nifedipine (NDNIF) when exposed to sunlight or some kinds of artificial lights. NIF photo-degradation products do not contribute to clinical activity, thus prevention of photo-degradation of NI...